Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia

The Wiskott-Aldrich syndrome protein (WASP; encoded by the gene WAS) and its homologs are important regulators of the actin cytoskeleton, mediating communication between Rho-family GTPases and the actin nucleation/crosslinking factor, the Arp2/3 complex. Many WAS mutations impair cytoskeletal control in hematopoietic tissues, resulting in functional and developmental defects that define the X-linked Wiskott-Aldrich syndrome (WAS) and the related X-linked thrombocytopenia (XLT). These diseases seem to result from reduced WASP signaling, often through decreased transcription or translation of the gene. Here we describe a new disease, X-linked severe congenital neutropenia (XLN), caused by a novel L270P mutation in the region of WAS encoding the conserved GTPase binding domain (GBD). In vitro, the mutant protein is constitutively activated through disruption of an autoinhibitory domain in the wild-type protein, indicating that loss of WASP autoinhibition is a key event in XLN. Our findings highlight the importance of precise regulation of WASP in hematopoietic development and function, as impairment versus enhancement of its activity give rise to distinct spectra of cellular defects and clinical phenotypes.

[1]  G. Lathrop,et al.  Easy calculations of lod scores and genetic risks on small computers. , 1984, American journal of human genetics.

[2]  Mike Carson,et al.  RIBBONS 2.0 , 1991 .

[3]  A A Schäffer,et al.  Faster sequential genetic linkage computations. , 1993, American journal of human genetics.

[4]  K. Welte,et al.  Abnormal regulation in the signal transduction in neutrophils from patients with severe congenital neutropenia: relation of impaired mobilization of cytosolic free calcium to altered chemotaxis, superoxide anion generation and F-actin content. , 1993, Experimental hematology.

[5]  L. Notarangelo,et al.  Studies of the expression of the Wiskott-Aldrich syndrome protein. , 1996, The Journal of clinical investigation.

[6]  Cécile Fizames,et al.  A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.

[7]  T. Kirchhausen,et al.  Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Schwartz,et al.  Mutation Spectrum in Patients with Wiskott-Aldrich Syndrome and X-linked Thrombocytopenia: Identification of Twelve Different Mutations in the WASP Gene , 1996, Thrombosis and Haemostasis.

[9]  O. Majdic,et al.  Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. , 1997, Blood.

[10]  S. Kanner,et al.  Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. , 1997, Blood.

[11]  K. Devriendt,et al.  Skewed X-chromosome inactivation in female carriers of dyskeratosis congenita. , 1997, American journal of human genetics.

[12]  L. Notarangelo,et al.  Defective actin polymerization in EBV‐transformed B‐cell lines from patients with the Wiskott–Aldrich syndrome , 1998, The Journal of pathology.

[13]  C. Kinnon,et al.  Absence of expression of the Wiskott-Aldrich syndrome protein in peripheral blood cells of Wiskott-Aldrich syndrome patients. , 1998, Clinical immunology and immunopathology.

[14]  Yoshimi Takai,et al.  Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP , 1998, Nature.

[15]  Markus G. Rudolph,et al.  The Cdc42/Rac Interactive Binding Region Motif of the Wiskott Aldrich Syndrome Protein (WASP) Is Necessary but Not Sufficient for Tight Binding to Cdc42 and Structure Formation* , 1998, The Journal of Biological Chemistry.

[16]  T D Pollard,et al.  The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Snapper,et al.  The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization. , 1999, Annual review of immunology.

[18]  R. Insall,et al.  Signaling to Actin Dynamics , 1999, The Journal of cell biology.

[19]  U. Francke,et al.  Novel mutations in the Wiskott‐Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes , 1999, Human mutation.

[20]  K. Siminovitch,et al.  Structure of Cdc42 in complex with the GTPase-binding domain of the ‘Wiskott–Aldrich syndrome’ protein , 1999, Nature.

[21]  A Shcherbina,et al.  WASP levels in platelets and lymphocytes of wiskott-aldrich syndrome patients correlate with cell dysfunction. , 1999, Journal of immunology.

[22]  P. Sansonetti,et al.  Activation of the Cdc42 Effector N-Wasp by the Shigella flexneri Icsa Protein Promotes Actin Nucleation by Arp2/3 Complex and Bacterial Actin-Based Motility , 1999, The Journal of cell biology.

[23]  M. Kirschner,et al.  Mechanism of N-Wasp Activation by Cdc42 and Phosphatidylinositol 4,5-Bisphosphate , 2000, The Journal of cell biology.

[24]  C Bos,et al.  Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. , 2000, Blood.

[25]  T. Pollard,et al.  Activation by Cdc 42 and PIP 2 of Wiskott-Aldrich Syndrome protein ( WASp ) Stimulates Actin Nucleation by Arp 2 / 3 Complex , 2000 .

[26]  Thomas D. Pollard,et al.  Activation by Cdc42 and Pip2 of Wiskott-Aldrich Syndrome Protein (Wasp) Stimulates Actin Nucleation by Arp2/3 Complex , 2000, The Journal of cell biology.

[27]  W. Lim,et al.  Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. , 2000, Science.

[28]  Michael K. Rosen,et al.  Autoinhibition and activation mechanisms of the Wiskott–Aldrich syndrome protein , 2000, Nature.

[29]  P. Sigler,et al.  Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. , 2000, Science.

[30]  Michael L. Dustin,et al.  The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling , 2000, Nature Immunology.

[31]  D. Brooks,et al.  CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. , 2000, Arthritis and rheumatism.